Medical Devices in Thoughts from the Centre

Devices that can remotely monitor/manage conditions could drive medtech growth, but business-model changes may be needed

By Glenn Snyder, principal, Medtech Practice leader, Deloitte Consulting LLP

Medtech

Our report, The future unmasked: Predicting the future of healthcare and life sciences in 2025, highlights, among other things, healthcare’s move from episodic care to improving and maintaining the health and well- being of our population and supporting health ageing; an expectation that care will be designed around people not place; and the crucial role of MedTech and the Internet of Medical Things in driving value based care and influencing how the future will play out. This week’s blog, by Glen Snyder, our MedTech Practice leader in Deloitte consulting, appeared first as a US Center Health Forward Blog on 27 May and takes a closer look at an issue that links the aforementioned predictions, namely the role of medical devices in remotely monitoring and manging healthcare and how and why MedTech’s business models may need to change to stay ahead of consumer-focused, tech savvy companies that are entering the market.

Continue reading

Posted on 04/06/2021 | 0 Comments

How MedTech companies will drive the future of health

By Karen Taylor, Director, Centre for Health Solutions and Michel De Ridder, Partner, Deloitte Belgium, Regulatory compliance

Banner image-30-04

Last week my colleague Michel De Ridder and I participated in the annual MedTech Europe Forum 2021, where we delivered a presentation on our Deloitte Centre for Health Solutions research report 'Predicting the future of healthcare and life sciences in 2025: The future unmasked'. Our focus was on our sixth prediction 'MedTech and the IOMT are crucial drivers of value-based care'. However, we also discussed the implications of findings in our November 2020 research paper, ‘Winning in the future of MedTech’, underpinned by our global campaign on the Future of Health.i Following our presentation, we ran an ‘Ask the expert session’ to discuss emerging issues in relation to IP management. This week’s blog highlights the main themes that we discussed and explores the implications for MedTech companies’ role in the future of health. 

Continue reading

Posted on 30/04/2021 | 0 Comments

Start-up nation: The Future of Medtech is underway in Israel

By Glenn Snyder, principal, MedTech Practice leader, Deloitte Consulting LLP, and Arod Balissa, manager, Deloitte Catalyst | Tel Aviv

Cover

As we highlight in the six prediction of our report ‘The future unmasked, predicting the future of healthcare and life sciences in 2025’, MedTech companies have a critical role in driving the future of health, using transformative technology to enhance products and services, enabling 4P medicine and driving value-based care. Companies are also beginning to develop sophisticated data analytics capabilities and work more closely with end users to leverage AI and robotic technologies to improve patient outcomes. This week, we are sharing a blog by Glenn Snyder, Deloitte’s US MedTech Practice leader and Arod Balissa a manager at the Tel Aviv Deloitte Catalyst, in which they explore how MedTech is transforming health and care in Israel.

Continue reading

Posted on 19/03/2021 | 0 Comments

The future unmasked: conscious care and greater collaboration

By Karen Taylor, Samrina Bhatti and Krissie Ferris, Deloitte Centre for Health Solutions

Wheel-blog

This is the last week in the staggered launch of the final two predictions in our report ‘The future unmasked: Predicting the future of healthcare and life sciences in 2025’. Our predictions: ‘Healthcare and life sciences companies have prioritised decarbonisation’, and ‘Clusters of trusted partnerships have accelerated innovation’ explore two crucial developments in the evolving relationship between the stakeholders in the health ecosystem. These are the increased priority companies are giving to reducing their carbon footprints and the growth in trusted partnerships and collaborations between stakeholders. We also examine the impact that the COVID-19 pandemic has had in accelerating the pace of change.

Continue reading

Posted on 11/12/2020 | 0 Comments

The future unmasked: In 2025, healthcare is integrated, digital-first, and patient-centred

By Karen Taylor, Samrina Bhatti and Krissie Ferris, Deloitte Centre for Health Solutions

Wheel-blog

 

This is week three in our staggered launch of our predictions report ‘The future unmasked: Predicting the future of healthcare and life sciences in 2025’. This week, we have released predictions five and six: ‘Care is designed around people not place’ and ‘Medtech and the IOMT are crucial drivers of value-based care’. This week’s blog explores these two predictions.

Continue reading

Posted on 30/11/2020 | 0 Comments

Why I am inspired by the life sciences sector

By Mike DeLone, US life sciences leader, Deloitte LLP

Blog

I am particularly pleased this week to share with you a blog by Mike DeLone, the national sector leader for Deloitte’s US Life Sciences practice. Mike’s clear articulation of why he is feeling inspired by what he is seeing in the life sciences sector, resonated strongly with me, and I hope will resonate with those reading this blog.

Continue reading

Posted on 31/07/2020 | 0 Comments

Coalitions and collaborations are driving COVID-19 tests, treatments, and vaccines

By Greg Reh, Deloitte Global 's Life Sciences & Health Care practice

Blog

This week we are delighted to share with you a blog written by Greg Reh who leads the life sciences practice for Deloitte Global. The focus is on partnerships and collaborations which have been a feature of the industry for a number of years — particularly in terms of preventing infections and communicative diseases in underserved parts of the world. However, the COVID-19 pandemic has elevated the importance and viability of collaborations, both inside and outside of the life sciences sector, and has accelerated activity, including increasing dialogue and commitment among key industry stakeholders.

Continue reading

Posted on 24/07/2020 | 0 Comments

COVID-19: Shaping the future regulation of emergency medical equipment supply

By Paul  van Geffen and Eleonora  Lena, Deloitte Risk Advisory

Covid-green

The COVID-19 pandemic has disrupted everyone’s daily lives and touched every industry across the world. While many countries had influenza and other pandemic preparedness plans in place prior to COVID-19, no one was fully prepared for the speed and indiscriminate spread of the disease. Indeed, in many countries the demand for appropriate medical devices and equipment quickly outstripped supply, leading to critical shortages, particularly of ventilators and personal protective equipment (PPE). Consequently, traditional and novel medical equipment manufacturers have pivoted many of their activities to meet this demand. At the same time, international and national regulators have had to adapt their approach to granting market approval. These changes have implications for the future of medical device regulation.

Continue reading

Posted on 12/06/2020 | 0 Comments

COVID-19 is prompting Medtech to adapt to a rapidly changing world

By Glenn Snyder, principal, MedTech Practice leader, and Bill Murray, specialist executive, MedTech Practice, Deloitte Consulting LLP

Blog

This week’s blog is by Deloitte’s Medical Technology sector leader in the US, Glenn Snyder and his colleague, Bill Murray, and first appeared on the Deloitte US Health Forward Blog on 3 April 2020.

We are still in the early stages of the COVID-19 health emergency, but many medtech companies have already shifted their attention to addressing the immediate needs of the medical community. Some companies, for example, are ramping up production of ventilators, surgical masks, test kits, and other products that are in short supply. Some of them are collaborating with other medtech companies or organizations from outside the sector. Distilleries, cosmetics manufacturers, and even coffee roasters are pitching in to produce hand-sanitizers for first-responders.1,2,3

Continue reading

Posted on 29/05/2020 | 0 Comments

COVID-19 testing: how it works and why we need it urgently

By Karen Taylor, Director, and Maria João Cruz, Research Analyst, Centre for Health Solutions

Covid-orange

According to the World Health Organization (WHO), rapid testing of patients who meet the suspected case definition for COVID-19 is a priority for determining the clinical management and policy response to control the outbreak.1 Diagnostic testing for COVID-19 is critical to track the spread of this novel virus, understand its epidemiology, inform health managers of each case, and suppress transmission.2 Currently, different countries have implemented different testing strategies, depending on the availability of diagnostics kits and reagents, and on the capacity and capability of the healthcare system. However, there has been a global call to increase the speed and capacity for testing to help isolate cases and flatten the peak. This week’s blog explores the importance of testing, what tests can be done and which are already available.

Continue reading

Posted on 09/04/2020 | 0 Comments